Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
ClearPoint Neuro Shares Are Trading Higher After the Company Announced the Early Repayment of a $10 Million Convertible Note to PTC Therapeutics. Additionally, Lake Street Raised Its Price Target on the Stock From $11 to $15.
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
Lake Street analyst Frank Takkinen maintains $ClearPoint Neuro(CLPT.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 46.7% and a total average return of 1.1% over
Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT)
Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT)
Lake Street Maintains Buy on ClearPoint Neuro, Raises Price Target to $15